Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Journals
One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet.
nytimes.com/…/jose-baselga-cancer-memorial-sloan-kettering
OpenEdition vous propose de citer ce billet de la manière suivante :
Boris Hauray (9 septembre 2018). Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Journals. MEDICI. Consulté le 16 janvier 2026 à l’adresse https://doi.org/10.58079/rc2m

